Session Details

Cell Processing Track Session 4 - Post-Infusion to Commercialization
Wednesday, May 29, 2019 02:45 PM - 04:15 PM 
Room 220
Co-Chairs:

Mara Neal, SH(ASCP)MT, MS, MBA, Cook Regentec, USA
Vicki Antonenas, BSc, MSc, Westmead Hospital, Australia

Speakers:

Ending the Process - Clinical Challenges of Cellular Therapy Product Infusion
Kenneth Micklethwaite, MBBS, PhD, FRACP, FRCPA, Westmead Hospital, Australia

Decision Criteria and Tracking of Infused Cell Products
Virginia Litwin, PhD, Caprion Biosciences Inc., Canada

Lessons Learned in Transferring Cellular Therapy Products from Academia to Commercialization
Bruce Levine, PhD, University of Pennsylvania, United States

Vicki Antonenas MSc|BSc
Laboratory Director
Westmead Hospital
Chairman


Mara Neal MBA|SH(ASCP), MS
Director, Strategic Alliances
Cook Regentec
Chairman


Bruce Levine PhD
Barbara and Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania
Speaker


Virginia Litwin PhD
Vice President, Immunology
Caprion Biosciences
Speaker


Kenneth Micklethwaite MBBS PhD FRACP FRCPA
Haematologist
Westmead Hospital
Speaker